PanNETs represent a heterogeneous group of tumours, presenting either as hormonally active tumours (producing gastrin, insulin, glucagon, somatostatin, vasoactive intestinal peptide or growth hormone-releasing hormone) or as non-functioning tumours. This evidence concerns the gene INS and neoplasm.